The Impact of Natural Compounds on S-Shaped Aβ42 Fibril: From Molecular Docking to Biophysical Characterization

Stefano Muscat, Lorenzo Pallante, Filip Stojceski, Andrea Danani, Gianvito Grasso, Marco A. DeriuInternational Journal of Molecular Sciences 2020 · DOI

TL;DR

This study uses computational modeling (molecular docking and dynamics simulations) to investigate how 57 natural compounds interact with and potentially destabilize S-shaped amyloid-beta (Aβ42) fibrils, a key component in Alzheimer's disease. The research identifies five compounds that show significant destabilizing effects, offering insights into potential therapeutic strategies for Alzheimer's by targeting the structural integrity of toxic amyloid aggregates.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by the accumulation of amyloid-beta (Aβ) peptides into toxic aggregates, primarily Aβ42 fibrils. While the amyloid cascade hypothesis is a leading theory, current treatments offer only symptomatic relief and often come with severe side effects. There's a critical need for novel, effective, and safe therapeutic strategies that can directly target and disrupt the formation or stability of these toxic Aβ aggregates. Natural compounds have shown promise in preclinical and clinical studies for AD, but their precise mechanisms of action remain largely unclear, hindering rational drug design. This paper aims to shed light on these mechanisms by computationally evaluating the impact of a diverse set of natural compounds on the S-shaped Aβ42 fibril, a particularly stable and toxic polymorphic form.

Methods

The researchers employed a multi-pronged computational approach:

  • Molecular Dynamics (MD) Simulations: They began by simulating the compound-free S-shaped Aβ42 pentamer to obtain representative starting structures for subsequent analyses. Long MD simulations (150 ns) were then performed on complexes of the Aβ42 fibril with the most promising natural compounds.
  • Molecular Docking: Ensemble docking was used to predict the binding poses and affinities of 57 natural compounds to the S-shaped Aβ42 fibril. This involved screening a library of compounds and identifying those with the lowest binding energies.
  • MM-GBSA Binding Energy Estimation: This method was used to estimate the binding energy between the docked ligands and the Aβ42 receptor complexes, helping to rank the compounds.
  • Biophysical Characterization (Computational): Several parameters were calculated from the MD simulations to quantify the effect of the compounds on the fibril's structure:
  • Beta-sheet structure probability: To assess changes in the characteristic secondary structure of amyloid fibrils.
  • Order parameter: To measure the overall structural order and alignment of the fibril.
  • Inter-chain interaction area: To quantify the contact surface between adjacent protein chains, indicating the fibril's structural integrity.
  • Pharmacophore Modeling: This technique was used to identify shared chemical features among the most effective destabilizing compounds, aiming to define a pharmacophore model for future drug design.

Datasets

Not discussed in the paper. The study utilized existing protein structure databases (PDB ID: 2MXU for the S-shaped Aβ42 fibril) and a library of 57 natural compounds sourced from previous literature and PubChem.

Key Insights and Ideas

  • S-shaped Aβ42 Fibril as a Target: The study focuses on the S-shaped Aβ42 fibril, which is noted for its superior conformational and mechanical stability compared to other forms, making it a particularly relevant and challenging target for therapeutic intervention.
  • Diverse Mechanisms of Action: Natural compounds don't all act the same way. The research identified three distinct mechanisms:
  • Inter-chain Destabilization: Compounds like 6-shogaol and oleuropein insert themselves between adjacent fibril chains, directly disrupting the fibril's structure.
  • Pocket Distortion: Compounds such as curcumin, gossypin, and piceatannol bind to specific pockets within the S-shaped fibril, causing a broader conformational change.
  • Pocket Stabilization: Other compounds showed a tendency to stabilize existing binding pockets, potentially reinforcing the fibril structure rather than disrupting it.
  • Key Residue Interactions: Specific residues (E11–F19 and I32–L34) were identified as crucial for binding and effective interaction with many of the investigated compounds, suggesting these regions are important for the fibril's stability and potential drug targets.
  • Pharmacophore for Design: The identification of shared pharmacophore features among the most effective destabilizing compounds provides a blueprint for designing new, more potent amyloid destabilizers.

Key Results

  • Identification of Five Key Compounds: Out of 57 natural compounds screened, five demonstrated significant destabilizing effects on the S-shaped Aβ42 fibril: 6-shogaol, oleuropein, curcumin, gossypin, and piceatannol.
  • Quantifiable Structural Changes: These five compounds significantly reduced:
  • Beta-sheet structure content (e.g., oleuropein, gossypin, piceatannol, curcumin, and 6-shogaol reduced it).
  • The fibril's order parameter.
  • The inter-chain interaction area.
  • Mechanism I Compounds (6-shogaol, Oleuropein): These were particularly effective at interposing between protein chains, leading to significant destabilization.
  • Mechanism II Compounds (Curcumin, Gossypin, Piceatannol): These compounds docked into specific pockets, causing overall protein conformational changes.
  • Pharmacophore Model: A shared pharmacophore model for destabilizing compounds was identified, featuring three hydrogen bond acceptors (HBA), one hydrogen bond donor (HBD), one aromatic ring (AR), and one hydrophobic interaction (H).

Limitations and Future Work

  • In Silico Focus: The study is entirely computational. While powerful for screening and mechanism elucidation, it cannot fully replicate the complexity of in vivo processes. Experimental validation is crucial.
  • Preformed Fibrils: The simulations focused on the action of compounds on already formed S-shaped Aβ42 fibrils, not on the entire fibrillogenesis process from monomer to fibril.
  • Single Compound Effects: The study primarily investigated the effects of individual compounds. Future work could explore combinations of compounds, as well as the impact of varying ligand concentrations.
  • Metal Ion Influence: The authors suggest future studies could investigate the role of metal ions, which are known to influence amyloid aggregation, in ligand-target binding.
  • Broader Compound Screening: Expanding the library of natural compounds to include those with similar chemical features to the identified effective ligands could yield further insights.
  • Experimental Validation: The most promising compounds identified in this study warrant further experimental investigation to confirm their therapeutic potential.

Summary updated

Abstract

The pursuit for effective strategies inhibiting the amyloidogenic process in neurodegenerative disorders, such as Alzheimer's disease (AD), remains one of the main unsolved issues, and only a few drugs have demonstrated to delay the degeneration of the cognitive system. Moreover, most therapies induce severe side effects and are not effective at all stages of the illness. The need to find novel and reliable drugs appears therefore of primary importance. In this context, natural compounds have shown interesting beneficial effects on the onset and progression of neurodegenerative diseases, exhibiting a great inhibitory activity on the formation of amyloid aggregates and proving to be effective in many preclinical and clinical studies. However, their inhibitory mechanism is still unclear. In this work, ensemble docking and molecular dynamics simulations on S-shaped Aβ<sub>42</sub> fibrils have been carried out to evaluate the influence of several natural compounds on amyloid conformational behaviour. A deep understanding of the interaction mechanisms between natural compounds and Aβ aggregates may play a key role to pave the way for design, discovery and optimization strategies toward an efficient destabilization of toxic amyloid assemblies.
BibTeX
@article{muscat2020impact,
  author = {Stefano Muscat and Lorenzo Pallante and Filip Stojceski and Andrea Danani and Gianvito Grasso and Marco A. Deriu},
  title = {{The Impact of Natural Compounds on S-Shaped Aβ42 Fibril: From Molecular Docking to Biophysical Characterization}},
  journal = {International Journal of Molecular Sciences},
  year = {2020},
  doi = {10.3390/ijms21062017},
}
Figure